Cargando…
Comparison of anti-Vi IgG responses between two clinical studies of typhoid Vi conjugate vaccines (Vi-DT vs Vi-TT)
Salmonella enterica serovar Typhi (S. Typhi) is a causative agent for typhoid fever and especially critical in developing countries. Although clinical studies for various typhoid conjugate vaccines (TCVs) have been performed, there are no comparative data on the immune responses of vaccines due to l...
Autores principales: | Lee, Eun Young, Park, Ju Yeon, Kim, Deok Ryun, Song, Manki, Sahastrabuddhe, Sushant, Kim, Hun, Chon, Yun, Yang, Jae Seung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156108/ https://www.ncbi.nlm.nih.gov/pubmed/32203521 http://dx.doi.org/10.1371/journal.pntd.0008171 |
Ejemplares similares
-
Safety and immunogenicity of a Vi-DT typhoid conjugate vaccine: Phase I trial in Healthy Filipino adults and children
por: Capeding, Maria Rosario, et al.
Publicado: (2018) -
Immunogenicity, safety and reactogenicity of a Phase II trial of Vi-DT typhoid conjugate vaccine in healthy Filipino infants and toddlers: A preliminary report
por: Capeding, Maria Rosario, et al.
Publicado: (2020) -
Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial
por: Kumar Rai, Ganesh, et al.
Publicado: (2022) -
Immune persistence and response to booster dose of Vi-DT vaccine at 27.5 months post-first dose
por: Capeding, Maria Rosario, et al.
Publicado: (2022) -
ViTT: Vision Transformer Tracker
por: Zhu, Xiaoning, et al.
Publicado: (2021)